NASDAQ:HQY HealthEquity - HQY Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding HealthEquity, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $57.69 +1.67 (+2.98%) (As of 03/27/2023 12:00 AM ET) Add Compare Share Share Today's Range$57.04▼$58.5050-Day Range$52.44▼$67.4152-Week Range$52.27▼$79.20Volume455,926 shsAverage Volume822,059 shsMarket Capitalization$4.88 billionP/E RatioN/ADividend YieldN/APrice Target$81.25 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media HealthEquity MarketRank™ ForecastAnalyst RatingModerate Buy2.82 Rating ScoreUpside/Downside40.8% Upside$81.25 Price TargetShort InterestBearish3.92% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.39Based on 15 Articles This WeekInsider TradingN/AProj. Earnings Growth49.07%From $1.08 to $1.61 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.29 out of 5 starsMedical Sector231st out of 995 stocksBusiness Services, Not Elsewhere Classified Industry35th out of 93 stocks 3.4 Analyst's Opinion Consensus RatingHealthEquity has received a consensus rating of Buy. The company's average rating score is 2.82, and is based on 9 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $81.25, HealthEquity has a forecasted upside of 40.8% from its current price of $57.69.Amount of Analyst CoverageHealthEquity has only been the subject of 3 research reports in the past 90 days. Previous Next 2.0 Short Interest Percentage of Shares Shorted3.92% of the float of HealthEquity has been sold short.Short Interest Ratio / Days to CoverHealthEquity has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in HealthEquity has recently increased by 8.36%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldHealthEquity does not currently pay a dividend.Dividend GrowthHealthEquity does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for HQY. Previous Next 3.0 News and Social Media Coverage News SentimentHealthEquity has a news sentiment score of 0.39. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.66 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 15 news articles for HealthEquity this week, compared to 4 articles on an average week.Search Interest14 people have searched for HQY on MarketBeat in the last 30 days. This is an increase of 27% compared to the previous 30 days.MarketBeat Follows8 people have added HealthEquity to their MarketBeat watchlist in the last 30 days. This is an increase of 700% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, HealthEquity insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.80% of the stock of HealthEquity is held by insiders.Percentage Held by Institutions99.54% of the stock of HealthEquity is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.9 Earnings and Valuation Earnings GrowthEarnings for HealthEquity are expected to grow by 49.07% in the coming year, from $1.08 to $1.61 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of HealthEquity is -186.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of HealthEquity is -186.09, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Growth RatioHealthEquity has a PEG Ratio of 2.47. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioHealthEquity has a P/B Ratio of 2.58. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About HealthEquity (NASDAQ:HQY) StockHealthEquity, Inc. provides range of solutions for managing health care accounts. The firm's offers its solutions for employers, health plans, brokers, consultants and financial advisors. Its services include HAS, FSA, HRA, DCRA, 401(k), Commuter, COBRA and HIA. It also offers products like healthcare saving and spending platform, health savings accounts, investment advisory services, reimbursement arrangements, and healthcare incentives. The company was founded by Stephen D. Neeleman on September 18, 2002 and is headquartered in Draper, UT.Read More Receive HQY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter. Email Address HQY Stock News HeadlinesMarch 26, 2023 | americanbankingnews.comHealthEquity (NASDAQ:HQY) Stock Price Down 5.7% Following Analyst DowngradeMarch 25, 2023 | americanbankingnews.comHealthEquity (NASDAQ:HQY) Price Target Lowered to $69.00 at Deutsche Bank AktiengesellschaftMarch 27, 2023 | Weiss Ratings (Ad)Fed's Shocking New Plan to Control Your MoneyThe Federal Reserve has a disturbing plan that is getting ready to roll out as soon as May. This is a lot more than printing trillions of dollars or manipulating interest rates. It's about every checking account, every purchase and every money transfer in America — including yours and mine. March 24, 2023 | finance.yahoo.comHealthEquity, Inc. (NASDAQ:HQY) Q4 2023 Earnings Call TranscriptMarch 24, 2023 | americanbankingnews.comHealthEquity (NASDAQ:HQY) Rating Reiterated by Royal Bank of CanadaMarch 21, 2023 | finance.yahoo.comHealthEquity (HQY) Q4 Earnings and Revenues Beat EstimatesMarch 20, 2023 | finance.yahoo.comHealthEquity (NASDAQ:HQY) rises 6.5% this week, taking three-year gains to 33%March 19, 2023 | americanbankingnews.comHealthEquity (HQY) Scheduled to Post Earnings on TuesdayMarch 27, 2023 | Investor Place Media (Ad)Biden To Unleash "Choke Point" Operation On America?Biden's disturbing new government program may be worse than Obama's. You are at risk for having your bank account frozen. A former bank regulator is blowing the whistle on Biden's frightening plan to take over your money. Discover the immediate steps you need to take now.March 15, 2023 | finance.yahoo.comHealthEquity (HQY) Surges 10.0%: Is This an Indication of Further Gains?March 14, 2023 | finance.yahoo.comHealthEquity (HQY) Reports Next Week: Wall Street Expects Earnings GrowthMarch 2, 2023 | finance.yahoo.comHealthEquity Sets Date to Announce Fourth Quarter and Fiscal Year End ResultsFebruary 23, 2023 | finance.yahoo.comWhat Makes HealthEquity (HQY) a Good Investment Avenue?February 7, 2023 | finance.yahoo.comHealthEquity Continues to Lead in Gender Equality and as a Top WorkplaceFebruary 5, 2023 | finance.yahoo.comA Look At The Intrinsic Value Of HealthEquity, Inc. (NASDAQ:HQY)December 21, 2022 | finance.yahoo.comAre Medical Stocks Lagging Gilead Sciences (GILD) This Year?December 15, 2022 | finance.yahoo.comHow Much Upside is Left in HealthEquity (HQY)? Wall Street Analysts Think 30%December 15, 2022 | finance.yahoo.com3 Medical Services Stocks to Buy Amid Industry ChallengesDecember 13, 2022 | finance.yahoo.comInnovative Benefits Plan Demonstrates How HSAs can Further Pay EquityDecember 9, 2022 | finance.yahoo.comHealthEquity, Inc. (NASDAQ:HQY) Q3 2023 Earnings Call TranscriptDecember 9, 2022 | finance.yahoo.comHealthEquity (HQY) Stock Falls 1.6% Despite Q3 Earnings BeatDecember 9, 2022 | finance.yahoo.comHealthEquity Third Quarter 2023 Earnings: Beats ExpectationsDecember 6, 2022 | finance.yahoo.comHealthEquity (HQY) Q3 Earnings and Revenues Surpass EstimatesNovember 11, 2022 | finance.yahoo.comIs Now The Time To Look At Buying HealthEquity, Inc. (NASDAQ:HQY)?November 1, 2022 | markets.businessinsider.comAnalysts Offer Insights on Financial Companies: Healthequity (HQY) and Invitation Homes (INVH)November 1, 2022 | finance.yahoo.comHealthEquity Ranked No. 1 HSA Provider on its 20th Anniversary, Releases New Edition of the HSA GuidebookOctober 22, 2022 | msn.comAnalyst Ratings for HealthEquitySee More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive HQY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for HealthEquity and its competitors with MarketBeat's FREE daily newsletter. Email Address HQY Company Calendar Last Earnings12/06/2021Today3/27/2023Next Earnings (Estimated)6/05/2023Fiscal Year End1/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Business services, not elsewhere classified Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:HQY CUSIPN/A CIK1428336 Webwww.healthequity.com Phone(801) 727-1000Fax801-727-1005Employees3,695Year FoundedN/APrice Target and Rating Average Stock Price Forecast$81.25 High Stock Price Forecast$94.00 Low Stock Price Forecast$69.00 Forecasted Upside/Downside+45.0%Consensus RatingModerate Buy Rating Score (0-4)2.82 Research Coverage11 Analysts Profitability EPS (Most Recent Fiscal Year)($0.31) Trailing P/E RatioN/A Forward P/E Ratio51.87 P/E Growth2.47Net Income$-44,290,000.00 Net Margins-3.03% Pretax Margin-4.42% Return on Equity3.50% Return on Assets2.13% Debt Debt-to-Equity Ratio0.48 Current Ratio2.92 Quick Ratio3.01 Sales & Book Value Annual Sales$861.75 million Price / Sales5.50 Cash Flow$2.71 per share Price / Cash Flow20.67 Book Value$22.40 per share Price / Book2.50Miscellaneous Outstanding Shares84,640,000Free Float82,270,000Market Cap$4.74 billion OptionableOptionable Beta0.80 Key ExecutivesJon KesslerPresident, Chief Executive Officer & DirectorTyson MurdockChief Financial Officer & Executive Vice PresidentElimelech RosnerChief Technology Officer & Executive VPJody DietelSenior Vice President-Compliance & Regulatory NewsDelano LaddSecretary, Executive VP & General CounselKey CompetitorsPhreesiaNYSE:PHRThe Ensign GroupNASDAQ:ENSGSotera HealthNYSE:SHCIonis PharmaceuticalsNASDAQ:IONSPrometheus BiosciencesNASDAQ:RXDXView All CompetitorsInsiders & InstitutionsVictory Capital Management Inc.Sold 250,191 shares on 3/10/2023Ownership: 0.734%Rockefeller Capital Management L.P.Bought 167 shares on 3/6/2023Ownership: 0.009%Voya Investment Management LLCBought 89,697 shares on 2/28/2023Ownership: 0.144%Teachers Retirement System of The State of KentuckyBought 21,880 shares on 2/22/2023Ownership: 0.040%Northwestern Mutual Investment Management Company LLCSold 4,362 shares on 2/21/2023Ownership: 0.009%View All Insider TransactionsView All Institutional Transactions HQY Stock - Frequently Asked Questions Should I buy or sell HealthEquity stock right now? 11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for HealthEquity in the last year. There are currently 2 hold ratings and 9 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HQY shares. View HQY analyst ratings or view top-rated stocks. What is HealthEquity's stock price forecast for 2023? 11 equities research analysts have issued twelve-month target prices for HealthEquity's shares. Their HQY share price forecasts range from $69.00 to $94.00. On average, they anticipate the company's share price to reach $81.25 in the next twelve months. This suggests a possible upside of 45.0% from the stock's current price. View analysts price targets for HQY or view top-rated stocks among Wall Street analysts. How have HQY shares performed in 2023? HealthEquity's stock was trading at $61.64 on January 1st, 2023. Since then, HQY shares have decreased by 9.1% and is now trading at $56.02. View the best growth stocks for 2023 here. When is HealthEquity's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, June 5th 2023. View our HQY earnings forecast. How were HealthEquity's earnings last quarter? HealthEquity, Inc. (NASDAQ:HQY) announced its quarterly earnings results on Monday, December, 6th. The company reported $0.35 EPS for the quarter, meeting analysts' consensus estimates of $0.35. The firm earned $180 million during the quarter, compared to the consensus estimate of $185.44 million. HealthEquity had a positive trailing twelve-month return on equity of 3.50% and a negative net margin of 3.03%. The business's revenue for the quarter was up .3% on a year-over-year basis. During the same quarter last year, the business posted $0.30 EPS. What ETFs hold HealthEquity's stock? ETFs with the largest weight of HealthEquity (NASDAQ:HQY) stock in their portfolio include Motley Fool Mid-Cap Growth ETF (TMFM), Putnam Sustainable Future ETF (PFUT), Global X FinTech ETF (FINX), SPDR S&P Health Care Services ETF (XHS), Nuveen Small Cap Select ETF (NSCS), iShares U.S. Healthcare Providers ETF (IHF), MFAM Small-Cap Growth ETF (MFMS) and ALPS Disruptive Technologies ETF (DTEC). What guidance has HealthEquity issued on next quarter's earnings? HealthEquity updated its FY 2024 earnings guidance on Wednesday, March, 22nd. The company provided earnings per share guidance of $1.74-$1.87 for the period, compared to the consensus estimate of $1.77. The company issued revenue guidance of $960.00 million-$975.00 million, compared to the consensus revenue estimate of $961.58 million. What is Jon Kessler's approval rating as HealthEquity's CEO? 359 employees have rated HealthEquity Chief Executive Officer Jon Kessler on Glassdoor.com. Jon Kessler has an approval rating of 95% among the company's employees. This puts Jon Kessler in the top 30% of approval ratings compared to other CEOs of publicly-traded companies. 69.0% of employees surveyed would recommend working at HealthEquity to a friend. What other stocks do shareholders of HealthEquity own? Based on aggregate information from My MarketBeat watchlists, some companies that other HealthEquity investors own include NVIDIA (NVDA), Shopify (SHOP), Block (SQ), Okta (OKTA), PayPal (PYPL), Twilio (TWLO), Trade Desk (TTD), Alibaba Group (BABA), Casino, Guichard-Perrachon Societe Anonyme (COP) and Input Capital (INP). What is HealthEquity's stock symbol? HealthEquity trades on the NASDAQ under the ticker symbol "HQY." Who are HealthEquity's major shareholders? HealthEquity's stock is owned by many different retail and institutional investors. Top institutional shareholders include William Blair Investment Management LLC (3.53%), JPMorgan Chase & Co. (2.53%), Brown Advisory Inc. (2.35%), Fred Alger Management LLC (1.87%), Geode Capital Management LLC (1.85%) and ArrowMark Colorado Holdings LLC (1.78%). Insiders that own company stock include Adrian T Dillon, Angelique Christine Hill, Ashley Dreier, Darcy G Mott, Darcy G Mott, Debra Charlotte Mccowan, Delano Ladd, Edward Bloomberg, Frank Corvino, Frank Medici, Gayle Furgurson Wellborn, Ian Sacks, Jon Kessler, Larry L Trittschuh, Stuart B Parker and William Robert Otten. View institutional ownership trends. How do I buy shares of HealthEquity? Shares of HQY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is HealthEquity's stock price today? One share of HQY stock can currently be purchased for approximately $56.02. How much money does HealthEquity make? HealthEquity (NASDAQ:HQY) has a market capitalization of $4.74 billion and generates $861.75 million in revenue each year. The company earns $-44,290,000.00 in net income (profit) each year or ($0.31) on an earnings per share basis. How many employees does HealthEquity have? The company employs 3,695 workers across the globe. How can I contact HealthEquity? HealthEquity's mailing address is 15 WEST SCENIC POINTE DRIVE SUITE 100, DRAPER UT, 84020. The official website for the company is www.healthequity.com. The company can be reached via phone at (801) 727-1000, via email at rputnam@healthequity.com, or via fax at 801-727-1005. This page (NASDAQ:HQY) was last updated on 3/27/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.